News

By Jonah Comstock November 21, 2018
With just five and a half million people spread out over more than 100 million square miles of land — and a nationalized system pledged to provide high-quality free medical care to them all — the nation of Finland is about as perfect a testbed for connected health innovation as you can imagine. Add in a surplus of developers left over from Nokia’s mobile phone heyday, and you have a country with...
By Leontina Postelnicu November 21, 2018
Oxford-based Sensyne Health announces partnership with EY. Former UK science minister Lord (Paul) Drayson’s Sensyne Health has signed a Strategic Advisory Services agreement with EY to scale up the business and build on its business model. The company has inked partnerships with three NHS trusts in England to analyse anonymised patient data using its clinical AI technology to accelerate medical...
By Laura Lovett November 20, 2018
Age played a major role in Chilean women’s attitudes toward text message reminders for Papanicolaou (Pap) testing, according to a small study published by JMIR mHealth and uHealth. The study set out to investigate the barriers preventing Chilean women from getting tested for cervical cancer by setting up focus groups to talk to patients. Twenty-seven women between the ages of 25 and 64 who did...
By Dave Muoio November 20, 2018
reSET — a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA — is now commercially available for clinicians to prescribe to their patients, according to a release from Pear Therapeutics and Sandoz, a division of Novartis with which Pear partnered back in April. But while physical prescription drugs are usually handled through a pharmacy, the process...
NovioSense's artist conception of its device in use.

NovioSense's artist conception of its device in use.

By Jonah Comstock November 20, 2018
Last week, Alphabet subsidiary Verily Life Sciences announced the end, at least for the foreseeable future, of its glucose-sensing contact lens collaboration with Novartis. Verily CTO Brian Otis gave his thoughts in a blog post at the time, stressing the learnings the company got from the project. In a recent interview with MobiHealthNews, Novartis Global Head of Digital Development Jacob LaPorte...
By Laura Lovett November 20, 2018
A recent study published in JMIR Mental Health found that despite the growth of smartphone ownership in recent years, the use of mental health apps among patients remains low.  In fact, in the study’s survey, which was given to 186 patients being treated for mental health conditions, only about 10 percent reported actively using a mental health app.  “Our results suggest that while mental health...
By Dave Muoio November 20, 2018
Merck KGaA, Darmstadt, and Silicon Valley-area big data company Palantir Technologies announced a joint venture that will focus on building an analytics and collaborative technology platform for cancer researchers. Called Syntropy, the Boston-based effort will rely on Palantir Foundry to power its data integration platform. Any research data shared across participating groups will be transparent...

​Photo: Courtesy of L'Oréal USA

By Dean Koh November 19, 2018
Last week, L'Oréal announced that its La Roche-Posay My Skin Track UV—the first battery-free wearable electronic to measure UV exposure is available for sale through apple.com and select U.S. Apple Store locations. La Roche-Posay My Skin Track UV measures both UVA and UVB rays, and provides instant status updates while storing up to three months of data. The battery-free sensor is activated by...

Editor's Pick